NDA[removed]S-010 Page 3 AGRYLIN® (anagrelide hydrochloride) Capsules Rx only

First Page		Document Content
Date: 2009-03-31 15:46:55 Essential thrombocytosis Anagrelide Thrombocytosis Polycythemia vera Aspirin Methadone Medicine Chemistry Organochlorides		NDA[removed]S-010 Page 3 AGRYLIN® (anagrelide hydrochloride) Capsules Rx only Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 95,23 KB Share Document on Facebook

	Registered PM (EN) 09-Mar-2015: Administrative NDS - Company name change (New 3D version to include the Submission Control No) DocID: 1m6q1 - View Document
	Registered PM (EN) 09-Mar-2015: Administrative NDS - Company name change (New 3D version to include the Submission Control No) DocID: 1lIPi - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AGRYLIN safely and effectively. See full prescribing information for AGRYLIN. AGRYLIN® (anagrelide hydrochloride) c DocID: Khvt - View Document
	Brief Report Survival of Patients With PMF Mature Survival Data for 176 Patients Younger Than 60 Years With Primary Myelofibrosis Diagnosed Between 1976 and 2005: DocID: DtHv - View Document
	M:aDocuments20-333-executive-summary.doc DocID: B71X - View Document